|
Volumn 169, Issue 3, 2001, Pages 265-271
|
Drug discovery and target validation
|
Author keywords
Drug discovery; Genomics; Pharmaceuticals; Proteomics
|
Indexed keywords
ANABOLIC AGENT;
ANTIRHEUMATIC AGENT;
CASPASE INHIBITOR;
CONFERENCE PAPER;
DRUG TARGETING;
GENE EXPRESSION;
HUMAN;
OSTEOARTHRITIS;
OSTEOCLAST;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN LOCALIZATION;
TEMPOROMANDIBULAR JOINT DISORDER;
ANIMALS;
BONE RESORPTION;
CASPASES;
CYSTEINE PROTEINASE INHIBITORS;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
GENOMICS;
HUMANS;
PROTEOME;
STRUCTURE-ACTIVITY RELATIONSHIP;
TEMPOROMANDIBULAR JOINT DISORDERS;
|
EID: 0034954744
PISSN: 14226405
EISSN: None
Source Type: Journal
DOI: 10.1159/000047890 Document Type: Conference Paper |
Times cited : (17)
|
References (15)
|